Taku Tashiro
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Suppressing FUT8 with a Novel Small Molecule Inhibitor Ameliorates Inflammation in Murine T Cell-mediated Colitis Models.
Journal: Cellular and molecular gastroenterology and hepatology
Published: July 24, 2025
Safety and Effectiveness of Oral Budesonide after Endoscopic Balloon Dilation in Patients with Crohn's Disease: A Multicenter Prospective Intervention Study.
Journal: Inflammatory intestinal diseases
Published: April 21, 2025
Optimizing 5-Aminosalicylic Acid Maintenance Treatment in Ulcerative Colitis from the Patient and Physician Perspective: A Cross-sectional Multicenter Study.
Journal: Crohn's & colitis 360
Published: February 25, 2025
Selection of anti-cytokine biologics by pretreatment levels of serum leucine-rich alpha-2 glycoprotein in patients with inflammatory bowel disease.
Journal: Scientific reports
Published: February 29, 2024
Elderly onset age is associated with low efficacy of first anti-tumor necrosis factor treatment in patients with inflammatory bowel disease.
Journal: Scientific reports
Published: October 08, 2021
Lysophosphatidylserines derived from microbiota in Crohn's disease elicit pathological Th1 response.
Lysophosphatidylserines derived from microbiota in Crohn's disease elicit pathological Th1 response.
Journal: The Journal of experimental medicine
Published: June 13, 2021
Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma.
Journal: BMC cancer
Published: April 13, 2021
Exacerbation of non-steroidal anti-inflammatory drug-induced enteropathy in C-C chemokine receptor type 7-deficient mice.
Journal: Journal of gastroenterology and hepatology
Published: February 27, 2021
Last Updated: 09/26/2026